Plain-English translation of NCT05302375 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing iPath*D, an online platform that helps cancer patients who are experiencing depression symptoms. The tool shows you your depression screening results and then guides you through different treatment options—both online and in-person—so you can choose what works best for you and connect directly to care.
Many cancer patients struggle with depression, but they often don't know where to turn for help or what their options are. This trial exists to see whether an easy-to-use online tool can help more patients get screened for depression and find mental health support without extra barriers.
You likely qualify if…
You likely don't qualify if…
You will log into your online iPath*D account to review your depression screening score and what it means. You'll then work through an interactive tool that shows you different evidence-based treatment options available to you—such as therapy, support groups, or other mental health services—and you'll have the option to connect directly to the treatment path that appeals to you most. The study involves about 30 cancer patients at one rural cancer center.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
National Cancer Institute (NCI)
Enrollment target
~30 participants
Started
July 2024
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Susan Tarczewski
Dartmouth College
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.